<DOC>
	<DOCNO>NCT01211639</DOCNO>
	<brief_summary>The purpose study explore host genetic mutation may render individual subject susceptible ( resistant ) develop Progressive Multifocal Leukoencephalopathy ( PML ) . Samples also collect determine Deoxyribonucleic Acid ( DNA ) sequence JC Virus ( JCV ) . Analysis JC Virus ( JCV ) genome may provide information viral genotype may associate high pathogenicity , help identify individual may high risk develop Progressive Multifocal Leukoencephalopathy ( PML ) due chronic infection pathogenic variant JC Virus ( JCV ) .</brief_summary>
	<brief_title>Genetic Evaluation Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy</brief_title>
	<detailed_description>Deoxyribonucleic acid ( DNA ) analyze natalizumab-treated subject develop Progressive Multifocal Leukoencephalopathy ( PML ) . The genetic analysis subject directly seek mutation could identify subject risk .</detailed_description>
	<mesh_term>Leukoencephalopathies</mesh_term>
	<mesh_term>Leukoencephalopathy , Progressive Multifocal</mesh_term>
	<mesh_term>Natalizumab</mesh_term>
	<criteria>Key Subjects confirm PML treatment Natalizumab NOTE : Other protocol define Inclusion/ Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>